{"id":152014,"date":"2020-11-13T00:53:41","date_gmt":"2020-11-13T05:53:41","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/exacerbation-of-neurological-symptoms-and-covid-19-severity-in-patients-with-preexisting-neurological-disorders-and-covid-19-a-systematic-review\/"},"modified":"2024-08-17T19:07:11","modified_gmt":"2024-08-17T23:07:11","slug":"exacerbation-of-neurological-symptoms-and-covid-19-severity-in-patients-with-preexisting-neurological-disorders-and-covid-19-a-systematic-review","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/neurology\/exacerbation-of-neurological-symptoms-and-covid-19-severity-in-patients-with-preexisting-neurological-disorders-and-covid-19-a-systematic-review.php","title":{"rendered":"Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: A systematic review -&#8230;"},"content":{"rendered":"<p><p>This article was originally published here<\/p>\n<p>Clin Neurol Neurosurg. 2020 Nov 1:106349. doi: 10.1016\/j.clineuro.2020.106349. Online ahead of print.<\/p>\n<p>ABSTRACT<\/p>\n<p>BACKGROUND: Patients with chronic diseases likely develop severe 2019 coronavirus disease (COVID-19). However, little is known about the effects of COVID-19 on patients with neurological disorders. We conducted a systematic review to evaluate the severity of COVID-19 and its effect on neurological symptoms in patients with preexisting neurological disorder and COVID-19.<\/p>\n<p>METHODS: We searched the MEDLINE (PubMed) and medRxiv databases for reports of patients with both preexisting neurological disorders and COVID-19. Studies reporting data on changes in the symptoms of preexisting neurological disorders and\/or the severity of COVID-19 were included.<\/p>\n<p>RESULTS: Twenty-six articles with 2278 patients with preexisting neurological disorder and COVID-19 were identified. Of 232 patients, 74 (31.9 %) showed exacerbation of preexisting neurological symptoms of dementia (55\/92; 59.5 %), Parkinsons disease (10\/17; 58.8 %), epilepsy (1\/1; 100 %), and unspecified neurological disorders (8\/106; 7.5 %). Of 2168 patients, 478 (22.0 %) showed severe COVID-19 course. These included patients with cerebrovascular disease (86\/445; 19.3 %), dementia (70\/316; 22.2 %), Parkinsons disease (25\/214; 11.7 %), multiple sclerosis (28\/71; 39.4 %), spinal cord injury (5\/7; 71.4 %), epilepsy (10\/98; 10.2 %) and unspecified neurological disorders (254\/1011; 25 %).<\/p>\n<p>CONCLUSIONS: Patients with preexisting neurological disorders and COVID-19 may develop exacerbation of neurological symptoms and severe COVID-19. Clinicians should be aware of the risk of symptom exacerbation and severe COVID-19 in patients with preexisting neurological disease and should focus on the prevention and early care of COVID-19.<\/p>\n<p>PMID:33172719 | DOI:10.1016\/j.clineuro.2020.106349<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>The rest is here:<br \/>\n<a target=\"_blank\" href=\"https:\/\/www.docwirenews.com\/condition-center\/multiple-sclerosis-knowledge-hub\/exacerbation-of-neurological-symptoms-and-covid-19-severity-in-patients-with-preexisting-neurological-disorders-and-covid-19-a-systematic-review\/\" title=\"Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: A systematic review -...\" rel=\"noopener noreferrer\">Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: A systematic review -...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> This article was originally published here Clin Neurol Neurosurg. 2020 Nov 1:106349. doi: 10.1016\/j.clineuro.2020.106349 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/neurology\/exacerbation-of-neurological-symptoms-and-covid-19-severity-in-patients-with-preexisting-neurological-disorders-and-covid-19-a-systematic-review.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246864],"tags":[],"class_list":["post-152014","post","type-post","status-publish","format-standard","hentry","category-neurology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/152014"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=152014"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/152014\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=152014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=152014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=152014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}